We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XWhite Paper
January 16, 2012
The new EU Directive 2011/62/EU is intended to broaden and standardise the counterfeit protection of prescription medicines placed on the market of the European Union. It will have significant impacts in the area of pharmaceutical packaging, which in future will be required to include obligatory safety features that make it possible to verify the origins of medicinal products. Download this white paper to find out how Securikett is complying with this directive.
Download to find out more.